Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

"The Deceptive Dozen": The National Pediculosis Association Offers 12 Important Tips to Help Parents Avoid Misleading Information on Head Lice
  • USA - English


News provided by

NATIONAL PEDICULOSIS ASSOCIATION

Jun 03, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Boston, MA (PRWEB) June 03, 2014 -- As school winds down and children prepare for summer camp, the National Pediculosis Association (NPA) team has compiled a list of red flags to watch out for when seeking information on lice treatment and prevention. The “Deceptive Dozen” list includes some of the most commonly made statements that mislead parents, require fact-checking and put child health and wellness at unnecessary risk. Parents need to be aware of these questionable directives in order to avoid confusion and potentially harmful responses to head lice.

The Deceptive Dozen:

The reward is an environment of mutual assurance that everyone is doing the best that they can for the health of their children and their community.

Post this

1. Ads, articles or products that claim head lice are a nuisance and not a health hazard for children.

The treatment for head lice is the hazard when it involves pesticides. Pesticide treatments create a unique situation where both the person applying the treatment and the person being treated are at risk. Parents should be wary of vague directives requiring that a person only needs to “be treated.” Recommendations for treatment should include warnings of health risks associated with pesticide use and the availability of combing and manual removal as a safe alternative. (See http://www.headlice.org/downloads/whynonchem.pdf)

2. Assurances that head lice do not carry disease.

Pediculosis is the medical term for an infestation of lice. It is itself an infectious disease. Head lice are parasites specific to humans and require blood meals to survive. They have been associated with bacterial infections including impetigo and rickettsial diseases. (See http://www.headlice.org/news/research/index.htm ).

3. Assertions that head lice are not a hygiene issue.

To put it bluntly: Head lice are communicable human parasites that require blood for feeding, infest one’s hair and scalp, defecate, mate, and literally glue their eggs (nits) to hair to hatch new lice. This makes head lice a compelling hygiene issue for the people who have them. A chronic case of pediculosis challenges a person’s health and wellness.

4. “Nitwashing.”

“Nitwashing” is the use of deceptive lice product marketing language -- a ploy used to promote the idea of a product’s effectiveness and superiority. “Nitwashing” emphasizes an ability to repel or kill lice and nits with misleading promises that use of the product renders nit removal unimportant and unnecessary.    It is wise to be skeptical of marketers using “nitwashing” in product claims and advertising.

5. Labeling or claims that a lice treatment product is preventive, natural, non-toxic or not a pesticide.    

The word “natural” has become a meaningless buzz word used to imply safety. A chemical product designed to repel or kill lice and nits is still a pesticide, according to the US Environmental Protection Agency. (See: http://www.epa.gov/kidshometour/pest.htm ). This is true regardless of its ingredients. The assurances of preventive or non-toxicity requires independent scientific scrutiny and substantiation. Be cautious. http://www.ftc.gov/news-events/press-releases/2014/05/company-settles-ftc-charges-head-lice-prevention-claims-were

6. Failure to offer the alternative of combing, especially for those most vulnerable to the adverse effects of chemicals.

The FDA acknowledges combing as a non-chemical treatment option for managing head lice via screening, detecting and thoroughly removing lice and nits. Combing is a critical research tool used by product manufacturers. When combing is ignored or belittled as an effective option for parents; that’s a red flag! For some individuals, including pregnant women, nursing mothers and children with cancer, asthma or allergies, a non-chemical approach is critical. This group also includes children who have earlier been treated with pesticides for lice. http://www.headlice.org/downloads/whynonchem.pdf

7. Name-dropping: references to nationally known non-profit organizations or academic institutions to prove a point.

Parents report sometimes feeling intimidated when they try to voice their concerns about school policy on head lice. The names of non-profit organizations and academic institutions shouldn’t be misconstrued as endorsements, consensus, or mandates by these groups. Name-dropping can undermine essential fact-checking, open communication and the community cooperation needed to control a communicable disease.

8. Ads, products, claims or articles by “experts.”

The “expert’s” qualifications can be deceptive because their professional focus may be too narrow. Look for conflicts of interest. Pediculosis expertise requires a broad educational background in various scientific disciplines, especially public health toxicology, environmental health, and medical ethics.

9. Use of ‘no nit policy’ as a generic term for all policies.

Be aware that “no nit policies” vary from school to school. Some policies strictly exclude children with nits from the classroom. Others, consistent with NPA’s recommendation, proactively educate the community and empower parents to routinely screen, detect lice and nits early and deliver children to school free of lice and nits. http://www.headlice.org/downloads/nonitpolicy.htm

10. Products, ads, or information insisting that parents need professional help or medical training in order to care for a child with head lice.

We are unable to find a scientific basis to substantiate the assertion that parents need such professional help.

Not every family can afford to pay for services and many families are comfortable dealing with head lice on their own. Pediculosis can be well managed by informed parents empowered with accurate information and proper combing tools. Lice and nit removal service providers can play a beneficial role for families who choose to seek assistance. (Be aware that such services are most often without regulatory government oversight. Choosing a service requires parental attentiveness and caution.)

11. Ads, products or stories identifying chemical-resistant lice as “super lice”:

“Super lice” is a misleading and unnecessarily scary term often used to refer to chemical-resistant lice. The term conjures up an image of invincible bugs, making parents feel desperate or powerless to deal with them. Further, the FDA does not require warnings to consumers that a product may be less effective than claimed due to chemical resistance in lice. Without warning or knowledge of combing as a non-chemical alternative, parents resort to applying multiple pesticidal products in search of an effective remedy. This increases health risks. http://www.headlice.org/special/alert.htm

12. Ads, product information, or media articles which state that “parents can’t accurately identify lice or are too impatient to deal with the problem.”    

Parents are known to welcome education on this issue as part of a community approach. Most parents are able to control head lice in their families without lost class time or risky chemicals. For the child whose family is unable to take responsibility, for whatever reason, the school health system can be prepared to go the extra mile with sensitivity and safety to ensure the child is able to return to their group lice and nit free. NPA’s experience has been that most parents do best in managing head lice when they are afforded accurate information and respectful guidance. The reward is an environment of mutual assurance that everyone is doing the best that they can for the health of their children and their community.

The NPA hopes parents will find the “Deceptive Dozen” helpful in making better informed decisions about head lice and what is written about them. For more information you can visit http://www.headlice.org.

About The National Pediculosis Association:

The National Pediculosis Association®, Inc. (NPA), established in 1983, is a 501 c 3 non-profit volunteer organization, including scientific advisors dedicated to protecting children and their environment from the misuse and abuse of prescription and over-the-counter pesticide treatments for lice and scabies. Proceeds from the NPA's LiceMeister® comb allow the NPA to be self-sustaining and accomplish its mission. The NPA is the official sponsor of National Pediculosis Prevention Month kicked off each September to last the whole year long. CombFirst! 2014-2015 will be the NPA's 29th annual campaign.

Deborah Altschuler, NATIONAL PEDICULOSIS ASSOCIATION, +1 617-905-0176, [email protected]

Modal title

CombFirst! 2014-2015
CombFirst! 2014-2015
CombFirst! 2014-2015

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.